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Background: While their incidence is on the rise, twin pregnancies are associated with risks to the mothers and
their babies. This study aims to investigate the likelihood of adverse neonatal outcomes of twins following assisted
reproductive technology (ART) compared to non-ART twins.
Methods: A retrospective population study using the Australian National Perinatal Data Collections (NPDC) which
included 19,662 twins of ≥20 weeks gestational age or≥ 400 g birthweight in Australia. Maternal outcomes and
neonatal outcomes (preterm birth, low birth weight, resuscitation and neonatal death) were compared. Generalized
Estimating Equations were used to assess the likelihood of any neonatal outcomes, with adjusted odds ratio (AOR)
and 95% confidence intervals (CI) presented. Weinberg’s differential rule was used to estimate monozygotic twin rate.
Results: ART mothers were 3.3 years older than non-ART mothers. The rates of pregnancy-induced hypertension and
gestational diabetes were significantly higher for ART mothers than non-ART mothers (12.2% vs. 8.4%, p < 0.01) and (9.7%
vs. 7.5%, p < 0.01) respectively. The incidence of monozygotic twins was 2.0% for ART twins and 1.1% for non-ART twins.
Compared with non-ART twins, ART twins had higher rates of preterm birth (AOR 1.13, 95% CI: 1.05–1.22), low birth
weight (AOR 1.13, 95% CI: 1.05–1.22), and resuscitation (AOR 1.26, 95% CI: 1.17–1.36). Liveborn ART twins had 28% (AOR
1.28, 95% CI 1.09–1.50) increased odds of having any adverse neonatal outcome compared to liveborn non-ART twins,
especially for opposite-sex ART twins (AOR 1.42, 95% CI 1.11–1.82).
Conclusion: As ART twins had higher rates of adverse outcome, special prenatal care is recommended. Couples
accessing ART should be fully informed of the risk of adverse outcome of twin pregnancies.
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The rate of twin birth has been increased in the past
four decades. In the United States, the twin birth rate
has increased by 76%; from 1.9% in 1980 to 3.3% in 2009
[1]. In Australia, the rate of multiple deliveries has risen
by 15% from 1.3% in 1992 to 1.5% in 2012 [2, 3]. One of
the main reasons behind twining rate increase is the
introduction of assisted reproductive technology (ART)* Correspondence: Alex.Wang@uts.edu.au
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children representing 43% in the US [5] and 6.8% in
Australia and New Zealand [6].
Irrespective of the method of conception, twin pregnan-
cies have a greater risk of maternal and neonatal compli-
cations compared with singleton pregnancies [7]. When
the literature is limited to twins, it is inconsistent with
some studies reporting comparable maternal and neonatal
outcomes between ART and non-ART twin births [8]
while the others have found higher rates of maternal and
neonatal complications among ART twin births [4, 9].
There is a lack of national population-based studies in
Australia comparing ART and non-ART twins. The aim ofle is distributed under the terms of the Creative Commons Attribution 4.0
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neonatal outcomes among twins in Australia.
Methods
A national population-based retrospective cohort design
was used. The data source of this study is the Australian
National Perinatal Data Collection (NPDC) from 2007
to 2011. The NPDC includes information on mothers
and babies of all live births and stillbirths of at least
20 weeks gestation or at least 400 g birthweight [10].
Data on whether the pregnancy resulted from ART were
available for five out of the eight states and territories in
Australia (Victoria, Queensland, Western Australia,
Tasmania and the Australian Capital Territory) and were
included in this study. These five states and territories
represented approximately 60% of all births in Australia,
with data validation conducted at both state and national
levels [10]. The study population included 9831 sets of
twin deliveries, with 4580 (23.3%) ART twins and 15,082
(76.7%) non-ART twins.
Maternal characteristics included maternal age at deliv-
ery, pre-pregnancy body mass index (BMI), parity, smoking
during pregnancy, socioeconomic status, the Indigenous
status of the mother, and admitted patient elected accom-
modation status (public/private). Pre-existing maternal con-
ditions included pre-existing hypertension, and pre-existing
diabetes. Pregnancy complications included antepartum
haemorrhage, pregnancy-induced hypertension, and gesta-
tional diabetes. In NPDU, pregnancy-induced hypertension
included both gestational hypertension, and pre-eclampsia
[10]. Gestational hypertension is the blood pressure exceed-
ing 140/90 mmHg during pregnancy (after 20 weeks’ gesta-
tion) on two readings at least, of more than six hours apart
without pre-existing hypertension [11]. Preeclampsia is
defined as the presence of hypertension accompanied by
proteinuria, utero-placental or organ dysfunctions [11].
Gestational diabetes is the condition where diabetes is first
diagnosed during pregnancy and may disappear after giving
birth but considered as a risk factor for diabetes occurring
in the future [10].
Outcomes at birth included delivery method, preterm
birth (gestational age < 37 weeks), stillbirth, low birth-
weight (birthweight < 2500 g), Apgar score at 5 min, re-
suscitation at birth, admission to neonatal intensive care
unit or special care nursery (NICU/SCN), length of infant
stay in hospital in completed day and neonatal death
(within 28 days of birth). Among liveborn twins, a
combined measure ‘any adverse neonatal outcome’ was cre-
ated if a birth was preterm, low birthweight, Apgar score at
5 min < 7, required resuscitation, admitted to NICU/SCN
or neonatal death. Neonatal death is defined as the death of
a live born baby within 28 days of birth [10].
Maternal characteristics, pre-existing maternal condi-
tions, pregnancy complications and neonatal outcomeswere compared between ART and non-ART twins.
Chi-squared test for categorical variables and Student’s
t-test for continuous variables were used for the com-
parison. Generalized Estimating Equations was used to
assess the likelihood of ‘any adverse neonatal outcome’
following ART treatment, with odds ratio, adjusted odds
ratio (AOR) (adjusted for maternal age, parity, Indigen-
ous status of mother, pre-pregnancy BMI, and smoking
during pregnancy) and 95% confidence intervals (CI)
presented. Due to high proportion of missing data BMI
and smoking during pregnancy, a sensitivity analysis was
conducted by excluding smoking or BMI in the adjust-
ment. Weinberg’s differential rule was used to estimate
monozygotic twin rate [12]. Data were analysed using
Statistical Package for Social Sciences (SPSS) software,
version 22 (SPSS, Inc., Chicago, IL, USA).
Results
Table 1 shows maternal demographic characteristics
pre-existing conditions and pregnancy complications of
ART and non-ART groups. ART mothers were 3.3 years
older than non-ART mothers. Compared to non-ART
mothers, higher proportions of ART mothers were prim-
iparous, non-smoking, with normal BMI and with pri-
vate health insurance. One in four ART mothers was
from the least 20% disadvantaged group compared to <
20% of non-ART mothers (Table 1).
Antepartum hemorrhage rate was higher for ART
mothers than for non-ART mothers (5.7% vs. 4.5%, p =
0.02). The rates of pregnancy-induced hypertension and
gestational diabetes were also higher for ART mothers
than for non-ART mothers (12.2% vs. 8.4%, p < 0.01)
and (9.7% vs. 7.5%, p < 0.01) respectively (Table 1).
Table 2 shows the birth outcomes of ART and
non-ART twins. More than 60% of ART twins were born
by no labour caesarean section, significantly higher than
non-ART twins (46.7%). ART twins had a significantly
lower stillbirth rate than non-ART twins (1.4% vs. 2.3%,
p < 0.01) (Table 2).
Table 3 shows the monozygotic and dizygotic rate
among ART and non-ART twins. Of twins where sex is
available for both babies, same-sex twins made up 55.2%
of ART twins compared to 71.4% non-ART twins. Ac-
cording to Weinberg’s differential rule, there were 478
monozygotic ART twins and 6456 monozygotic non-ART
twins. This represents a monozygotic twin rate of 2.0% for
ART births and 1.1% for non-ART births (Table 3).
Table 4 shows the neonatal outcomes of liveborn ART
and non-ART twins. Liveborn ART twins had increased
odds of low Apgar score at 5 min (< 7), preterm birth,
low birthweight, requiring resuscitation, and neonatal
death than liveborn non-ART twins. Any adverse neo-
natal outcome was present for 89.0% of liveborn
non-ART twins compared to 95.3% of liveborn ART
Table 1 Demographics, pre-existing conditions and pregnancy complications of mothers of ART and non-ART twin sets, Australia, 2007–2011
Non-ART mothers (n = 7541) ART mothers (n = 2290) P value (chi-
squared test)No. % No. %
Maternal age, years
Mean ± SD 30.6 ± 5.4 33.9 ± 4.6 < 0.01*
< 30 3151 41.8 380 16.6 < 0.01
30–34 2451 32.5 874 38.2
35–39 1678 22.3 795 34.7
40–44 253 3.4 184 8.0
≥ 45 8 0.1 57 2.5
Pre-pregnancy BMI, kg/m2
< 20 124 1.6 36 1.6 0.44
20–24.9 516 6.8 213 9.3
25–29.9 424 5.6 157 6.9
30 + 334 4.5 115 5.0
Not stated 6134 81.3 1769 77.2
Parity
Primiparous 2773 36.8 1460 63.8 < 0.01
Multiparous 4768 63.2 830 36.2
Smoking during pregnancy
Smoked 1023 13.6 47 2.1 < 0.01
Did not smoke 4533 60.1 1709 74.6
Not stated 1985 26.3 534 23.3
Indigenous status of mothers
Non-Indigenous 7239 96.0 2280 99.6 < 0.01
Indigenous 295 3.9 9 0.4
Not stated 7 0.1 1 0.0
Admitted patient elected accommodation status
Public 5014 66.5 612 26.7 < 0.01
Private 2519 33.4 1676 73.2
Not stated 8 0.1 2 0.1
Pre-existing hypertension
Yes 82 1.1 34 1.5 0.13
No 7394 98.1 2242 97.9
Not stated 65 0.9 14 0.6
Pre-existing diabetes
Yes 42 0.6 13 0.6 0.96
No 7431 98.5 2262 98.8
Not stated 68 0.9 15 0.7
Antepartum haemorrhage
Yes 340 4.5 130 5.7 0.02
No 7201 95.5 2160 94.3
Pregnancy-induced hypertension
Yes 634 8.4 280 12.2 < 0.01
No 6907 91.6 2010 87.8
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Table 1 Demographics, pre-existing conditions and pregnancy complications of mothers of ART and non-ART twin sets, Australia, 2007–2011
(Continued)
Non-ART mothers (n = 7541) ART mothers (n = 2290) P value (chi-
squared test)No. % No. %
Gestational diabetes
Yes 567 7.5 222 9.7 < 0.01
No 6974 92.5 2068 90.3
*independent samples t-test
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born ART twins had 28% increased odds of having any
adverse neonatal outcome (AOR 1.28 95% CI 1.09–1.50)
compared to non-ART liveborn twins. The sensitivity
analysis by excluding BMI and smoking during preg-
nancy shows liveborn ART twins had 25% increased
odds of having any adverse neonatal outcome (AOR 1.25
95% CI 1.07–1.47) (Table 4).
Of liveborn twins where sex is available for both ba-
bies, same-sex ART twins had higher odds of preterm
birth (AOR 1.19; 95% CI 1.08–1.31) and requiring resus-
citation (AOR 1.28; 95% CI 1.16–1.41). The rate of any
adverse neonatal outcome was slightly higher in
same-sex ART twins than non-ART twins, but not sta-
tistically significant (AOR 1.20 95% CI 0.97–1.49).
For opposite-sex liveborn twins, ART twins had
higher odds of Apgar score at 5 min < 7 (AOR 1.53
95% CI 1.08–2.17), preterm birth (AOR 1.37 95% CI
1.20–1.55), low birthweight (AOR 1.34 95% CI 1.18–








No. % No. %
Delivery method
Vaginal 4587 30.4 758 16.6 < 0.01
Labour caesarean
section
3104 20.6 1011 22.1
No labour caesarean
section
7038 46.7 2764 60.3
Not stated 353 2.3 47 1.0
Birth status
Live birth 14,734 97.7 4516 98.6 < 0.01
Stillbirth (fetal death) 348 2.3 64 1.4
Preterm birth
Yes 8585 56.9 2818 61.5
- Spontaneous 4050 26.8 1104 24.1 < 0.01
- Induced or no
labor CS
4535 30.1 1714 37.4
No 6497 43.1 1762 38.51.42), and NICU/SCN admission (AOR 1.28 95% CI
1.13–1.46). Overall, opposite-sex liveborn ART twins
had a 42% increased risk of having any adverse neo-
natal outcome compared to non-ART twins (AOR
1.42 95% CI 1.11–1.82).
Discussion
The current analysis showed that ART twins had signifi-
cantly higher rates of adverse neonatal outcomes in
terms of preterm birth, low birthweight, the need for re-
suscitation and admission to NICU/SCN, long hospital
stay and birth by caesarean section. In addition, among
liveborn twins, ART twins had 28% increased odds of
having any adverse neonatal outcome (AOR 1.28, 95%
CI 1.09–1.50), especially for opposite-sex ART twins
(AOR 1.42, 95% CI 1.11–1.82).
We found that ART mothers had higher rates of ante-
partum haemorrhage, pregnancy-induced hypertension,
and gestational diabetes compared with non-ART
mothers. This is consistent with results from two other
studies [4, 9]. These adverse outcomes are partially
explained by the background of subfertility or infertility.
Women experiencing infertility, whether or not they
undertake ART, have higher rates of many adverse out-
comes when compared to women conceiving spontan-
eously within 12 months of trying [13].Table 3 Monozygotic and dizygotic ART and non-ART twins,
Australia, 2007–2011
Non-ART ART
No. % No. %
Opposite-sex twins 4300 28.6 2048 44.8
Same-sex twins 10,756 71.4 2526 55.2
Weinberg’s differential rule
Dizygotic twins 8600 4096
Monozygotic twins 6456 478
All births where sex
is available
582,475 24,071
Twins where sex is
available
15,056 4574
Dizygotic twin rate 1.5 17.0
Monozygotic rate 1.1 2.0
Table 4 Neonatal outcomes of liveborn ART and non-ART twins, Australia, 2007–2011
Total No. % OR (95% CI) AORa (95% CI) AORb (95% CI)
Apgar score at 5 min < 7
Non-ART 14,718 556 3.8 1.00
ART 4506 169 3.8 0.99 (0.83–1.18) 1.24 (1.02–1.52) 1.22 (1.01–1.50)
Preterm
Non-ART 14,734 8281 56.2 1.00 1.00
ART 4516 2764 61.2 1.23 (1.15–1.32) 1.13 (1.05–1.22) 1.13 (1.05–1.22)
Low birth weight
Non-ART 14,728 7415 50.3 1.00 1.00
ART 4515 2474 54.8 1.20 (1.12–1.28) 1.13 (1.05–1.22) 1.11 (1.03–1.20)
Resuscitation
Non-ART 14,727 7038 47.8 1.00 1.00
ART 4514 2569 56.9 1.44 (1.35–1.54) 1.26 (1.17–1.36) 1.29 (1.20–1.39)
Admission to intensive or special care nursery
Non-ART 14,355 8626 60.1 1.00 1.00
ART 4445 2945 66.3 1.30 (1.22–1.40) 1.08 (1.00–1.17) 1.09 (1.01–1.18)
Length of infant stay ≥5 days in hospital
Non-ART 14,733 10,084 68.4 1.00 1.00
ART 4516 3683 81.6 2.04 (1.88–2.21) 1.06 (0.97–1.17) 1.04 (0.95–1.14)
Neonatal death
Non-ART 14,734 262 1.8 1.00 1.00
ART 4516 93 2.1 1.16 (0.92–1.48) 1.32 (1.01–1.73) 1.31 (1.01–1.72)
Any adverse outcome
Non-ART 14,734 13,106 89.0 1.00 1.00
ART 4516 4304 95.3 2.52 (2.18–2.92) 1.28 (1.09–1.50) 1.25 (1.07–1.47)
aadjusted for maternal age, parity, Indigenous status of mother, pre-pregnancy BMI, and smoking during pregnancy
badjusted for maternal age, parity, and Indigenous status of mother
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rate of preterm birth is significantly higher among ART
twins than non-ART twins [9]. There are a number of
potential explanations for the increased risk of preterm
birth in ART births including the underlying maternal
characteristics such as subfertility or medical conditions
causing subfertility, obesity, and short stature, and the
ART treatment itself [14]. The increased risk of preterm
birth among twins is also partially explained by early
fetal loss in a higher order multiple pregnancy [15].
Pinborg and colleagues suggested that survivors of a
vanishing fetal hearts/gestational sacs were more likely
to be born preterm and with low birth weight [15].
Our results illustrated that the rate of low birthweight
in ART twins is significantly higher than non-ART
twins. This is consistent with findings in a previous sys-
tematic review which reported a 14% increase in the risk
of low birthweight among ART twins compared to
non-ART twins (RR 1.14, 95% CI 1.06–1.22) [16]. The
increased risk of low birthweight births in ART twins
can partially be explained by the higher preterm birthrate among ART twins compared with non-ART twins.
However, in this study, as in previous reports, the higher
rate of preterm birth alone does not explain the
increased risk of low birthweight [16, 17]. Multiple
pregnancies observed on the initial ultrasound is closely
linked to the increased risk of low birthweight [18].
During the study period, the twin delivery rates follow-
ing ART decreased from 24.5% in 2007 to 18.2% in 2011.
This has paralleled the increase in the proportion of single
embryo transfer in Australia from 63.7% in 2007 to 73.2%
in 2011 [6]. An Australian study suggested that a volun-
tary policy of single embryo transfer introduced in 2002
had a significant impact to the fall in the proportion of
ART multiple births [19]. Other studies further advocated
that continuing the policy of single embryo transfer would
prevent multiple pregnancies and improve overall mater-
nal and neonatal outcomes following ART [20, 21]. Luke
2017 concluded that transferring high quality and fewer
embryos is responsible for reducing the risk of multiple
births from ART treatments and ultimately reducing the
perinatal adverse outcomes [22].
Wang et al. BMC Pregnancy and Childbirth  (2018) 18:320 Page 6 of 7Our findings show that for opposite-sex twins, ART
twins had 42% increase in the likelihood of any adverse
neonatal outcome compared to non-ART twins.
Opposite-sex twins are all dizygotic twins which arise
from the fertilisation of two separate ova by two separate
sperm resulting in the formation of two separate zygotes
in natural pregnancy, or from multiple embryo transfers
in ART pregnancy. Virtually all dizygotic twins develop
their own placenta and membranes so are dizygotic
dichorionic diamniotic twins. Exceptional cases of mono-
chorionic dizygotic twins have been reported, however,
they are very rare [23]. The higher rate of any adverse out-
come in ART twins is possibly related to the underlying
infertility of the couples, the development of the embryo
in the laboratory or the transfers of multiple embryos [24].
Interestingly, we found that the rate of any adverse
neonatal outcome was higher among same-sex ART
twins than same-sex non-ART twins, but it was not sta-
tistically significant. Same sex twins can be monozygotic
or dizygotic twins, given that all monozygotic twins are
same-sex twins and about half of dizygotic twins are of
the same sex [23]. In natural pregnancy, monozygotic
twins develop by splitting zygote from the fertilisation of
a single ovum with a single sperm [25]. Subsequent pla-
centation depends on the time of zygote splitting, with
monozygotic dichorionic twins if splitting before day 3
and monozygotic monochorionic twins if splitting on
day 3 or after. In ART pregnancy, monozygotic twins re-
sult from the splitting of the single transferred embryo.
Since embryo transfers are virtually all on day 3 or after,
monozygotic monochorionic twins are likely to develop
[26]. However, we are unable to identify monozygotic
twins from same-sex dizygotic twins and compare the
neonatal outcomes between ART monozygotic twins
and non-ART monozygotic twins.
Without genetic testing and details of the number of
embryos transferred available, it is difficult to identify
monozygotic twins. One way to estimate the rate of
monozygotic twins is to use the sex of twin pairs by ap-
plying Weinberg’s differential rule [26]. Our data showed
that the proportion of same-sex twins was lower among
ART group (55.2%) than non-ART group (71.4%). This
proportion is slightly higher than Pinborg and colleagues
proportions of same-sex twins (50.8% among ART twins
and 65.3% among non-ART twins) [27] but, similar to
the Australian register [28]. Based on Weinberg’s differ-
ential rule, we estimated that among ART births, mono-
zygotic twin rate was 2.0 and 1.1% among non-ART
births. These estimates are higher than the monozygotic
twin rates from a systematic review where the rate was
0.9% (95% CI: 0.8–0.9%) in ART twins compared to 0.4%
(95% CI: 0.4–0.4) in naturally conceived twins [29].
The major strength of this study was the population
based-design. The advantage of population-based studiesrests on the inclusion of all patients in a given popula-
tion and are therefore have less tendency to selection
biases compared to the other types of observational
studies [30].
Twin pregnancies following ART treatment are highly
associated with multiple embryo transfers [31]. Unfortu-
nately, the number of embryos transferred is not
captured in the NPDC. We were unable to further inves-
tigate the ART twins by single or multiple embryo trans-
fers. In addition, there were other limitations in this
study. Apart from number of embryos transferred, other
detailed type of ART treatment and procedures were not
available in NPDC, such as fresh versus frozen embryo
transfer, cleavage versus blastocyst transfers. Studies
have demonstrated that the perinatal outcomes vary by
fresh versus frozen embryo transfers, autologous versus
donor treatment and cleavage versus blastocyst transfers
[20, 21, 32]. The information on BMI and smoking
during pregnancy was not stated for a large proportion
of mothers (80.4% for BMI and 25.6% for smoking
during pregnancy). This reflected that some jurisdictions
did not have smoking status and or BMI in their routine
data collection. The large proportion of mothers with
missing data on BMI and smoking during pregnancy
and the differential missing data between ART and
non-ART mothers would have reduced the validity of
the comparison and multivariate analysis.
Conclusion
This study using population cohort approach provided a
high level of evidence where a randomized controlled
trial is not feasible. The findings of this study strengthen
the evidence on of higher adverse neonatal outcomes
among ART twins than non-ART twins. These adverse
outcomes are likely related to both the type of concep-
tion and the underlying infertility of the women.
Women/couples accessing ART treatment should be
fully informed of the risk of adverse outcome of twin
pregnancies following ART treatment.
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